Maze Therapeutics, Inc. Contracts & Agreements
14 Contracts & Agreements
- Business Finance (4 contracts)
- Human Resources (5)
- Intellectual Property (1)
- Real Estate (1)
- Uncategorized (3)
- Amended and Restated Investors' Rights Agreement, dated November 26, 2024, by and among Maze Therapeutics, Inc. and certain of its stockholders (Filed With SEC on January 7, 2025)
- Form of Indemnity Agreement (Filed With SEC on January 7, 2025)
- 2018 Stock Option and Grant Plan, as amended, and forms of award agreements (Filed With SEC on January 7, 2025)
- 2019 Equity Incentive Plan, as amended, and forms of award agreements (Filed With SEC on January 7, 2025)
- 2025 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 7, 2025)
- 2025 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 7, 2025)
- Lease Agreement, dated September 27, 2019, by and among Maze Therapeutics, Inc. and HCP Oyster Point III LLC (Filed With SEC on January 7, 2025)
- Consulting Agreement, dated November 1, 2019, by and among Maze Therapeutics, Inc. and Charles Homcy, M.D (Filed With SEC on January 7, 2025)
- Advisor Agreement, dated July 1, 2021, by and among Maze Therapeutics, Inc. and Richard Scheller, Ph.D (Filed With SEC on January 7, 2025)
- Loan and Security Agreement, dated June 27, 2022, by and between Maze Therapeutics, Inc. and Pacific Western Bank, as amended (Filed With SEC on January 7, 2025)
- License Agreement, dated as of March 27, 2024, by and between Maze Therapeutics, Inc. and Shionogi & Co., Ltd (Filed With SEC on January 7, 2025)
- Non-Employee Director Compensation Policy (Filed With SEC on January 7, 2025)
- Form of Restated Offer Letter between Maze Therapeutics, Inc. and its senior executive officers (Filed With SEC on January 7, 2025)
- Amended and Restated Executive Severance and Change in Control Plan (Filed With SEC on January 7, 2025)
